Overview and Scope
Isobutyraldehyde is a chemical molecule with the formula (CH3)2CHCHO that is isomeric to n-butyraldehyde (butanal). It is a colorless volatile liquid with a pungent odor. It is used as a precursor to isobutanol, which is of interest in the context of butanol fuel.
Sizing and Forecast
The isobutyraldehyde market size has grown strongly in recent years. It will grow from $1.91 billion in 2023 to $2.02 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to chemical intermediates production, growing demand in the automotive industry, adhesives and sealants manufacturing, rubber chemicals manufacturing, paints and coatings industry demand.
The isobutyraldehyde market size is expected to see steady growth in the next few years. It will grow to $2.4 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing focus on bio-based chemicals, growth in renewable energy sector, advancements in the automotive fuel additives market, expansion of the adhesives and sealants market, rise in consumer demand for specialty flavors and fragrances. Major trends in the forecast period include innovations in paints and coatings formulations, increasing demand in pharmaceuticals, rising demand in agrochemicals, focus on bio-based production, technological advancements in production processes.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/isobutyraldehyde-global-market-report
Segmentation & Regional Insights
The isobutyraldehyde market covered in this report is segmented –
1) By Type: Food Grade, Pharma Grade, Industrial Grade, Other Types
2) By Form: Powder, Liquid, Other Forms
3) By Synthesis Method: Hydroformylation Of Propene, Oxidation Of Isobutane
4) By Application: Chemical Intermediates, Pharmaceuticals, Food And Fragrances, Fertilizers, Lubricants, Other Applications
Asia-Pacific was the largest region in the isobutyraldehyde market in 2023. The regions covered in the isobutyraldehyde market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13468&type=smp
Major Driver Impacting Market Growth
The growth in the consumption of fertilizers is expected to propel the growth of the isobutyraldehyde market going forward. Fertilizers refer to chemical compounds applied to plants to enhance their development by supplying necessary nutrients. These substances boost the plant's yield. Isobutyraldehyde is utilized in the production of fertilizers and pest control products. Isobutyraldehyde, in its liquid form, combined with the solid compound urea, acts as an uncoated nitrogen provider in fertilizers, gradually delivering essential nutrients to plants. For instance, in 2021, according to data from The World Bank Group, a US-based international organization providing loans to developing countries, the fertilizer consumption in Ireland was 130.1 kilograms per hectare of arable land in 2020, which increased to 139 kilograms per hectare of arable land in 2021. Therefore, the growth in consumption of fertilizers is driving the isobutyraldehyde market.
Key Industry Players
Major companies operating in the isobutyraldehyde market report are BASF SE, Merck & Co. Inc., Dow Inc., Mubychem Group, Mitsubishi Chemical Corporation, Sumitomo Chemical Co. Ltd., Arkema S.A., Eastman Chemical Company, Celanese Corporation, Airgas Inc., Formosa Plastics Corporation, Hangzhou DayangChem Co. Ltd., Grupa Azoty S.A., Luxi Chemical Group Co. Ltd., Yangmei Chemical Co. Ltd., JNC Group, Tokyo Chemical Industry Co. Ltd., Alfa Aesar, KH Neochem, Aceto Corporation, Kanto Chemical Co. Inc., Dairen Chemical Corporation, Inoue Perfumery MFG Co. Ltd., Otto Chemie Pvt. Ltd, Yancheng Chunzhu Aroma Co. Ltd., Shandong Jianlan Chemical Co. Ltd., Beijing Eastern Petrochemical Co. Ltd., Sinopec Qilu Petrochemical Corporation</b
The isobutyraldehyde market report table of contents includes:
1. Executive Summary
2. Isobutyraldehyde Market Characteristics
3. Isobutyraldehyde Market Trends And Strategies
4. Isobutyraldehyde Market - Macro Economic Scenario
5. Global Isobutyraldehyde Market Size and Growth
.
.
.
32. Global Isobutyraldehyde Market Competitive Benchmarking
33. Global Isobutyraldehyde Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Isobutyraldehyde Market
35. Isobutyraldehyde Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
COVID-19 Impact Analysis on Isobutyraldehyde Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the isobutyraldehyde market include BASF SE, Dow Chemical Company, Eastman, Arkema, Mitsubishi Chemical, Airgas, Inoue Perfumery MFG, Formosa Plastics, Shandong Jianlan Chemical, Beijing Eastern Petrochemical and Yancheng Chunzhu Aroma.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Isobutyraldehyde Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/isobutyraldehyde-market/download-sampleMarket DynamicsThe market is mainly driven by rising global demand for isobutyraldehyde, owing to growth in the production of paints and coatings, plasticizers, and fertilizers, and pharmaceuticals.
Isobutyraldehyde is made using many types of chemicals such as propene and n-butanol.
This hampers the global isobutyraldehyde market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
The Global Isobutyraldehyde Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on form and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Isobutyraldehyde (CAS 78-84-2) Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 @ https://www.decisiondatabases.com/ip/1175-isobutyraldehyde-industry-market-reportThe report also covers the complete competitive landscape of the global Isobutyraldehyde (CAS 78-84-2) market with company profiles of key players such as:BASF SEDow Chemical CompanyEastmanArkemaMitsubishi ChemicalAirgasInoue Perfumery MFGFormosa PlasticsShandong Jianlan ChemicalBeijing Eastern PetrochemicalYancheng Chunzhu AromaA detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By FormPowderLiquidOthersBy ApplicationChemical IntermediatesPharmaceuticalsFood & FragrancesFertilizersLubricantsOthersBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaDownload Free Sample Report of Global Isobutyraldehyde (CAS 78-84-2) Market @ https://www.decisiondatabases.com/contact/download-sample-1175The Global Isobutyraldehyde (CAS 78-84-2) Market has been exhibited in detail in the following chapters –Chapter 1 Isobutyraldehyde (CAS 78-84-2) Market PrefaceChapter 2 Executive SummaryChapter 3 Isobutyraldehyde (CAS 78-84-2) Industry AnalysisChapter 4 Isobutyraldehyde (CAS 78-84-2) Market Value Chain AnalysisChapter 5 Isobutyraldehyde (CAS 78-84-2) Market Analysis By FormChapter 6 Isobutyraldehyde (CAS 78-84-2) Market Analysis By ApplicationChapter 7 Isobutyraldehyde (CAS 78-84-2) Market Analysis By GeographyChapter 8 Competitive Landscape Of Isobutyraldehyde (CAS 78-84-2) CompaniesChapter 9 Company Profiles Of Isobutyraldehyde (CAS 78-84-2) IndustryPurchase the complete Global Isobutyraldehyde (CAS 78-84-2) Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-1175Other Reports by DecisionDatabases.com:Global Acetaldehyde Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027Global Paraformaldehyde Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Benzaldehyde Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
